Comparison of post-experimental outcome measures. by Neng Pan (5262032)

“…Following the intervention, the HIIT NW group exhibited a marked increase in limb lean mass, which led to a significant rise in the skeletal muscle index (SMI) (p < 0.001). …”

Schematic representation of the study protocol. by Neng Pan (5262032)

Out-of-sample Test Results of the Drop-off Decision Models: (a) ROC Curve of the First Forced Drop-off Decision Models; (b) ROC Curve for Second and More Forced Parking and Drop-of... by Fangyi Yang (18867853)

Patient selection flowchart. by Aihong Zheng (20571034)

Fig 3 - by Aihong Zheng (20571034)

S1 Fig - by Aihong Zheng (20571034)

Dynamic stability based on the Feasible Stability Region (FSR). by Hyung Suk Yang (20442438)

S2 Fig - by Aihong Zheng (20571034)

Fig 4 - by Aihong Zheng (20571034)

A particular class of CSR 22Gs are up-regulated in synMuv B mutants. by Ashwin Seetharaman (615458)

Demographic structure and Employment categorization. by Nehal Mohamed Eisa (21148787)

Burn out assessment throughout demographic structure of the participant. by Nehal Mohamed Eisa (21148787)

Stack column chart represent Emotional Exhaustion through demographic structure. by Nehal Mohamed Eisa (21148787)

Donut chart shows Demographic structure and Employment categorization. by Nehal Mohamed Eisa (21148787)

Stack column chart represent Depersonalization through demographic structure. by Nehal Mohamed Eisa (21148787)

Stack column chart represent Personal Accomplishment through demographic structure. by Nehal Mohamed Eisa (21148787)

i & ii: PCA represent the (i) 2d and (ii) 3d to identify the underlying dimensions of the lifestyle questions. by Nehal Mohamed Eisa (21148787)

Heatmap represents the criterion of health lifestyle survey. (Color guide is provided above each figure). by Nehal Mohamed Eisa (21148787)

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”